181 related articles for article (PubMed ID: 18221151)
21. Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.
Yang F; Zheng G; Fu T; Li X; Tu G; Li YH; Yao X; Xue W; Zhu F
Phys Chem Chem Phys; 2018 Sep; 20(37):23873-23884. PubMed ID: 29947629
[TBL] [Abstract][Full Text] [Related]
22. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
McDougall B; King PJ; Wu BW; Hostomsky Z; Reinecke MG; Robinson WE
Antimicrob Agents Chemother; 1998 Jan; 42(1):140-6. PubMed ID: 9449274
[TBL] [Abstract][Full Text] [Related]
23. Anti-HIV-1 integrase drugs: how far from the shelf?
Pani A; Marongiu ME
Curr Pharm Des; 2000 Mar; 6(5):569-84. PubMed ID: 10788597
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid.
Lee DJ; Robinson WE
J Virol; 2004 Jun; 78(11):5835-47. PubMed ID: 15140981
[TBL] [Abstract][Full Text] [Related]
25. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection.
Lin SS; Xu F; Liao PH; Yang CC
Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475
[TBL] [Abstract][Full Text] [Related]
26. Novel integrase inhibitors for HIV.
Prada N; Markowitz M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1087-98. PubMed ID: 20707594
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
28. In search of authentic inhibitors of HIV-1 integration.
Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
[TBL] [Abstract][Full Text] [Related]
29. The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Garvey EP; Johns BA; Gartland MJ; Foster SA; Miller WH; Ferris RG; Hazen RJ; Underwood MR; Boros EE; Thompson JB; Weatherhead JG; Koble CS; Allen SH; Schaller LT; Sherrill RG; Yoshinaga T; Kobayashi M; Wakasa-Morimoto C; Miki S; Nakahara K; Noshi T; Sato A; Fujiwara T
Antimicrob Agents Chemother; 2008 Mar; 52(3):901-8. PubMed ID: 18160521
[TBL] [Abstract][Full Text] [Related]
30. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
Witvrouw M; Debyser Z
Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
[TBL] [Abstract][Full Text] [Related]
31. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
[TBL] [Abstract][Full Text] [Related]
32. Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.
Di Santo R; Costi R; Roux A; Miele G; Crucitti GC; Iacovo A; Rosi F; Lavecchia A; Marinelli L; Di Giovanni C; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C
J Med Chem; 2008 Aug; 51(15):4744-50. PubMed ID: 18646746
[TBL] [Abstract][Full Text] [Related]
33. Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.
Serafin K; Mazur P; Bak A; Laine E; Tchertanov L; Mouscadet JF; Polanski J
Bioorg Med Chem; 2011 Aug; 19(16):5000-5. PubMed ID: 21767953
[TBL] [Abstract][Full Text] [Related]
34. Development of integrase inhibitors for treatment of AIDS: an overview.
Dubey S; Satyanarayana YD; Lavania H
Eur J Med Chem; 2007 Sep; 42(9):1159-68. PubMed ID: 17367896
[TBL] [Abstract][Full Text] [Related]
35. [Computer search for novel HIV-1 integrase inhibitors].
Akimov DV; Filimonov DA; Prikazchikova TA; Gottikh MB; Poroĭkov VV
Biomed Khim; 2005; 51(3):335-40. PubMed ID: 16104397
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
Li X; Vince R
Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300
[TBL] [Abstract][Full Text] [Related]
37. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
[TBL] [Abstract][Full Text] [Related]
38. Design and development of integrase inhibitors as anti-HIV agents.
Gupta SP; Nagappa AN
Curr Med Chem; 2003 Sep; 10(18):1779-94. PubMed ID: 12871104
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
[TBL] [Abstract][Full Text] [Related]
40. Resistance to HIV-1 integrase inhibitors: A structural perspective.
Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
